Meyzieu, France

Olivier Soula

USPTO Granted Patents = 33 

 

 

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 228(Granted Patents)


Location History:

  • Lyons, FR (2000)
  • Lyon, FR (2002)
  • Venissieux, FR (2016 - 2017)
  • Meyzieu, FR (2011 - 2020)

Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: **Olivier Soula: Innovator in Rapid-Acting Insulin Formulations**

Introduction

Olivier Soula, based in Meyzieu, France, is an esteemed inventor with an impressive portfolio of 33 patents. His work primarily focuses on advancing pharmaceutical formulations, particularly in the field of rapid-acting insulin. His innovations have significantly contributed to the management of diabetes, improving the quality of life for many patients.

Latest Patents

Among his latest patents is a rapid-acting insulin composition that includes a substituted citrate. This formulation is unique as it features an insulin in hexameric form combined with various substituted citrates, enhancing its performance in glucose regulation. Additionally, he has developed an innovative rapid-acting insulin formulation incorporating a substituted anionic compound, which consists of saccharide units linked through glycoside bonds. This formulation includes partially substituted carboxyl functional groups that can be salified, further improving its effectiveness as a pharmaceutical solution.

Career Highlights

Olivier Soula has made noteworthy advancements in the pharmaceutical industry, collaborating with prominent companies such as Adocia and Flamel Technologies. His extensive experience in these organizations reflects his commitment to innovation and excellence in research and development.

Collaborations

Throughout his career, Olivier has worked closely with remarkable coworkers, including Richard Charvet and Remi Soula. These collaborations have fostered a dynamic environment for creativity and the successful development of his patented technologies in insulin formulations.

Conclusion

Olivier Soula's contributions to the field of rapid-acting insulin are commendable. His patents are not only a reflection of his innovative spirit but also a testament to his dedication to enhancing diabetic care. With continued advancements and collaborative efforts, he remains a significant figure in the realm of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…